Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Updated on: May 11,2024

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Updated on:May 11,2024

Researcher unlocks mystery of 'chemo-brain,' identifies possible treatment

by Saint Louis UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI157738Though chemotherapy can be lifesaving, the cancer treatment often le

Updated on: January 30,2024

Researcher unlocks mystery of 'chemo-brain,' identifies possible treatment

by Saint Louis UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI157738Though chemotherapy can be lifesaving, the cancer treatment often le

Updated on:January 30,2024

The X chromosome is silenced in some male cancers

by Cell PressGraphical abstract depicting the study’s workflow. Credit:Cell Systems/Sadagopan et al.Cancer cells acquire genetic anomalies that allow them to grow and proliferate unchecked.

Updated on: February 03,2024

The X chromosome is silenced in some male cancers

by Cell PressGraphical abstract depicting the study’s workflow. Credit:Cell Systems/Sadagopan et al.Cancer cells acquire genetic anomalies that allow them to grow and proliferate unchecked.

Updated on:February 03,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on: May 09,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on:May 09,2024

ACA has provided better access to care for cancer survivors

(HealthDay)—Cancer survivors are more likely to have difficulty accessing and affording health care, but the proportion reporting these issues is decreasing, according to a study published online Marc

Updated on: March 27,2024

ACA has provided better access to care for cancer survivors

(HealthDay)—Cancer survivors are more likely to have difficulty accessing and affording health care, but the proportion reporting these issues is decreasing, according to a study published online Marc

Updated on:March 27,2024

Study examines Kentucky cancer survivors' increased risk of cancer incidence

by Elizabeth Chapin,University of KentuckyCredit: Unsplash/CC0 Public DomainWhile cancer survivors have an increased risk of developing cancer in the future, that risk is notably higher in Kentu

Updated on: February 20,2024

Study examines Kentucky cancer survivors' increased risk of cancer incidence

by Elizabeth Chapin,University of KentuckyCredit: Unsplash/CC0 Public DomainWhile cancer survivors have an increased risk of developing cancer in the future, that risk is notably higher in Kentu

Updated on:February 20,2024

Programming white blood cells to fight pancreatic cancer

by University of California - San DiegoPeter Yingxiao Wang, Ph.D. Credit: UC San Diego Jacobs School of EngineeringPancreatic cancer is the third most lethal cancer in the United States. Patients

Updated on: March 09,2024

Programming white blood cells to fight pancreatic cancer

by University of California - San DiegoPeter Yingxiao Wang, Ph.D. Credit: UC San Diego Jacobs School of EngineeringPancreatic cancer is the third most lethal cancer in the United States. Patients

Updated on:March 09,2024

A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on: April 06,2024

A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on:April 06,2024

Researchers discover potential attack strategy for aggressive breast cancer

by University of North Carolina at Chapel Hill School of MedicineThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained g

Updated on: June 22,2024

Researchers discover potential attack strategy for aggressive breast cancer

by University of North Carolina at Chapel Hill School of MedicineThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained g

Updated on:June 22,2024

Researchers discover a signaling molecule in neuroblastoma immunosuppression and aggressiveness

by Boston University School of MedicineCredit: Pixabay/CC0 Public DomainThe MYCN oncoprotein (proteins related to the growth of cancer cells) plays a key role in starting, advancing and making it

Updated on: March 20,2024

Researchers discover a signaling molecule in neuroblastoma immunosuppression and aggressiveness

by Boston University School of MedicineCredit: Pixabay/CC0 Public DomainThe MYCN oncoprotein (proteins related to the growth of cancer cells) plays a key role in starting, advancing and making it

Updated on:March 20,2024

New drug combination shows promise for common pediatric brain tumor

by Larry Frum,Johns Hopkins University School of MedicineThe introduction of everolimus with carboplatin treatment induces DNA damage in tumor cells and kills them. Credit: Johns Hopkins Kimmel

Updated on: March 06,2024

New drug combination shows promise for common pediatric brain tumor

by Larry Frum,Johns Hopkins University School of MedicineThe introduction of everolimus with carboplatin treatment induces DNA damage in tumor cells and kills them. Credit: Johns Hopkins Kimmel

Updated on:March 06,2024

Promise of liquid biopsy in cancer biomarker detection and prenatal screening

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersThe promise and challenges of liquid biopsy, an emerging, noninvasive method for targeted disease diagnosis and detection of canc

Updated on: May 23,2024

Promise of liquid biopsy in cancer biomarker detection and prenatal screening

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersThe promise and challenges of liquid biopsy, an emerging, noninvasive method for targeted disease diagnosis and detection of canc

Updated on:May 23,2024